# The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles

> **NCT04654741** · PHASE4 · UNKNOWN · sponsor: **Casa di Cura Privata Villa Mafalda** · enrollment: 396 (estimated)

## Conditions studied

- IVF
- Infertility

## Interventions

- **DRUG:** Medroxyprogesterone Acetate
- **DRUG:** Ganirelix Acetate

## Key facts

- **NCT ID:** NCT04654741
- **Lead sponsor:** Casa di Cura Privata Villa Mafalda
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 396 (ESTIMATED)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654741, "The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04654741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*